Higher soft drink consumption linked to increased risk of liver disease

Study found that higher soft drink consumption is associated with an increased risk of nonalcoholic fatty liver disease, especially in males, within a cohort of Mexican adults.

Biotheus and Hansoh Pharmaceutical expand ADC collaboration

Share this article Hansoh will gain exclusive global rights to use PM1080/HS-20117 to develop ADC products. Credit: Gorodenkoff / Shutterstock.com. Chinese biotech company Biotheus has

March 15, 2024

Study: Treat-to-Target Success in Early RA Is Durable

Success with “treat-to-target” therapy for early-stage rheumatoid arthritis (RA) lasted up to 20 years, according to researchers who followed up with participants in two of

April 5, 2024

Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders | Psychedelic Invest

MindBio to develop the novel psilocin prodrug for neuropsychiatric indications utilizing microdosing to reduce or eliminate hallucinogenic impact of psychedelic compounds Enveric Biosciences (NASDAQ: ENVB) (“Enveric”

May 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.